Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

China urges faster COVID-19 testing amid latest outbreak

Published 26/10/2021, 08:07
Updated 26/10/2021, 08:13

BEIJING (Reuters) - China is demanding faster and more accessible COVID-19 testing services in its latest effort to reinforce a zero-tolerance policy against the virus, even when cities have already scrambled to test millions in just a few days amid outbreaks.

Frequent testing, and sometimes mass testing, is standard practice in China's containment of domestically transmitted outbreaks in the past year, but health authorities say testing services remain unsatisfactory in parts of China amid flare-ups.

"Small clusters and sporadic infections have occurred in some areas, exposing problems such as the unreasonable locations of nucleic acid testing agencies, inconvenient services and delays in the returning of results," state media reported on Tuesday, citing the National Health Commission (NHC).

China is facing a new wave of infections involving nearly 200 locally transmitted symptomatic cases in 12 provincial areas since Oct. 17. Many of the infected were from remote parts of northwest China without as much health resources as major cities.

NHC said testing agencies should provide 24-hour services to the public and strive to have results within six hours for those who volunteer to be tested, according to state media reports.

NHC said in September that cities with over 5 million people should have the capacity to test everyone within three days.

While China is yet to approve self-testing kits for diagnosing COVID-19, swab tests that require professional labs to process samples are widely available.

Local governments have recently cut prices of swab tests, with certain tests charging as little as 13 yuan ($2.00) in the Chinese capital of Beijing.

Some officials in a small administrative division of the Chinese region of Inner Mongolia were reprimanded on Tuesday for bad management at sample collection sites that led to chaotic crowds during a division-wide testing drive.

© Reuters. Workers in protective suits work inside a makeshift nucleic acid testing laboratory during a mass testing following local cases of the coronavirus disease (COVID-19) in Lanzhou, Gansu province, China October 25, 2021. cnsphoto via REUTERS

Similar official admonishments were meted in the southern city of Zhangjiajie and in Yangzhou in the east during a cluster earlier this year.

Since the new coronavirus was found in late 2019, mainland China has reported 96,840 confirmed cases with symptoms, including both local and imported infections, with fatalities totalling 4,636.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.